|
| Status |
Public on Aug 04, 2008 |
| Title |
P238 lenalidomide pre-treatment |
| Sample type |
RNA |
| |
|
| Source name |
human myeloma cell P238 lenalidomide pre-treatment
|
| Organism |
Homo sapiens |
| Characteristics |
human myeloma cell P238 lenalidomide pre-treatment
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNeasy Mini Kit(50)
|
| Label |
Biotin
|
| Label protocol |
Biotinylated cRNA were prepared according to the standard affymetrix protocol
|
| |
|
| Hybridization protocol |
Following fragmentation, 10 microg of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
|
| Scan protocol |
GeneChips were scanned using GeneChip Scanner 3000
|
| Description |
human myeloma cell P238 lenalidomide pre-treatment
|
| Data processing |
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.
|
| |
|
| Submission date |
Jul 20, 2007 |
| Last update date |
Aug 14, 2011 |
| Contact name |
Yiming Zhou |
| E-mail(s) |
yzhou@uams.edu
|
| Phone |
(501)296-1503 1413
|
| Organization name |
Myeloma Institute for Research and Therapy
|
| Street address |
4301 West Markham St., Slot 776
|
| City |
Little Rock |
| State/province |
AR |
| ZIP/Postal code |
72205 |
| Country |
USA |
| |
|
| Platform ID |
GPL8300 |
| Series (1) |
| GSE8546 |
Gene Expression Changes in Myeloma Cells Following Short Term In-vivo Drug Exposure |
|
